Articles

As many full-service hospitals and health systems remain overwhelmed due to the COVID-19 pandemic, community cancer providers have been able to offer certain services to patients that may not be available at other institutions. How have these providers adapted to meet patients’ changing needs, and how are they keeping their doors open under unprecedented pressure?

Comprehensive Cancer Centers and IDNs

COVID-19

AVBCC COVID-19 Webcast Series

From shuttered laboratory experiments and interrupted clinical trial enrollments to a “shadow curve” of delayed cancer diagnoses, comprehensive cancer centers and integrated delivery networks (IDNs) across the country continue to grapple with the fallout from COVID-19.

Managed Care Update

COVID-19

AVBCC COVID-19 Webcast Series

One of the most significant questions for payers in the COVID-19 health ecosystem is, “Will reimbursement parity for telehealth services continue?” Leading representatives of major managed care organizations debate the prospects.

July 30, 2020: Update from Community Cancer Care Providers: COVID-19 Recovery, the Road Ahead

By Michael Diaz, MD; Barbara L. McAneny, MD; Ted Okon, MBA; Kashyap Patel, MD; Debra Patt, MD, PhD, MBA; Burt Zweigenhaft, PhD, D.Litt

COVID-19

As many full-service hospitals and health systems remain overwhelmed due to the COVID-19 pandemic, community cancer providers have been able to offer certain services to patients that may not be available at other institutions. How have these providers adapted to meet patients’ changing needs, and how are they keeping their doors open under unprecedented pressure?

July 29, 2020: Comprehensive Cancer Care Centers and Integrated Delivery Systems Update: COVID-19 Recovery, the Road Ahead

By Al B. Benson III, MD; Howard “Skip” Burris, III, MD, FACP, FASCO; Christian Downs, MHA, JD; Timothy Kubal, MBA, MD; Julian Schink, MD; Burt Zweigenhaft, PhD, D.Litt

COVID-19

From shuttered laboratory experiments and interrupted clinical trial enrollments to a “shadow curve” of delayed cancer diagnoses, comprehensive cancer centers and integrated delivery networks (IDNs) across the country continue to grapple with the fallout from COVID-19.

ASCO 2020 Lung Cancer Highlights

ASCO 2020 - Lung Cancer

Although the American Society of Clinical Oncology (ASCO) 2020 meeting was held virtually because of the COVID-19 pandemic, hundreds of abstracts, posters, and presentations were still made available to inform clinicians on the latest developments in the treatment of lung cancer. This publication features some of the key highlights from the meeting, which can be used to improve the management and care of patients with the disease.

July 28, 2020: Update from Managed Care Payers: COVID-19 Recovery, the Road Ahead

By Michael Kolodziej, MD; Bryan Loy, MD, MBA; Lee N. Newcomer, MD, MHA; Steven Peskin, MD, MBA, FACP; Michael Sherman, MD, MBA, MS; Burt Zweigenhaft, PhD, D.Litt

COVID-19

One of the most significant questions for payers in the COVID-19 health ecosystem is, “Will reimbursement parity for telehealth services continue?” Leading representatives of major managed care organizations debate the prospects.

Oncology Pharmacy Update

COVID-19

Shortages, inventory management, and challenges of in-home care were just a few of the topics in AVBCC’s wide-ranging webinar on how COVID-19 is affecting oncology pharmacy.

Patient Advocacy Update

COVID-19

As the COVID-19 pandemic stretches into its fifth month in the United States, advocacy groups providing support for patients with cancer are delivering essential support and services, while they worry about the long-term psychosocial impact on these patients and the future of clinical trials.

July 22, 2020: Patient Advocacy Update: COVID-19 Recovery, the Road Ahead

By Elizabeth Franklin, LGSW, ACSW; Patricia J Goldsmith; Amy Niles, MBA; Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG; Burt Zweigenhaft, PhD, D.Litt

COVID-19

As the COVID-19 pandemic stretches into its fifth month in the United States, advocacy groups providing support for patients with cancer are delivering essential support and services, while they worry about the long-term psychosocial impact on these patients and the future of clinical trials.

Top Trending Articles

Stay In The Know

Articles

Page 64 of 329

Top Trending Articles

Stay In The Know

We Value Your Feedback! Tell Us How You Consume Content